Skip to main content

Web Exclusives

Breast Cancer, Oncology

First-Line Pembrolizumab plus Chemotherapy Extend Progression-Free Survival in Patients with Metastatic Triple-Negative Breast Cancer

Phoebe Starr

Cosela First CDK4/6 Inhibitor FDA Approved to Reduce Chemotherapy-Induced Myelosuppression

Vyxeos Now Indicated for Treatment of Pediatric Patients with AML

FDA Approvals, Lymphoma

FDA Approved Ukoniq, New Targeted Therapy, for Marginal-Zone and Follicular Lymphoma

FDA Approvals, Lymphoma

FDA Approved Breyanzi, Novel CAR T-Cell Therapy, for Large B-Cell Lymphoma

FDA Approvals, Multiple Myeloma, Oncology

FDA Approved Pepaxto for Relapsed or Refractory Multiple Myeloma

FDA Approvals, Multiple Myeloma, Oncology

FDA Approved Abecma, First CAR T-Cell Therapy for Multiple Myeloma

ESMO 2020 Highlights

Sotorasib, First-in-Class KRAS G12C Inhibitor, Hailed as “Triumph of Drug Discovery”

Phoebe Starr

Keytruda plus Chemotherapy Approved for Unresectable or Metastatic Triple‑Negative Breast Cancer

Opdivo plus Yervoy First Immunotherapy Approved for Unresectable Malignant Pleural Mesothelioma

Page 14 of 37
Results 131 - 140 of 366